Kenya might find itself at crossroads after India announced a temporary suspension of exporting the Oxford/AstraZeneca vaccine to low-income countries following a surge of Covid-19 infections. The Chairman of Covid-19 Vaccine Development Task force, Willis Akhwale, was optimistic saying “there is still time for this vaccine. Health care workers, security personnel and teachers were among those scheduled to receive the jab from the 4.1 million doses, according to the Ministry of Health. Kenya is among 190 countries benefiting from the Covax facility and the country has so far received 1.02 million doses of the vaccine and a further 100,000 from the government of India. The 1.02 million doses were the first batch of the 4.1 million doses out of the 24 million expected.

Source: Standard Digital March 25, 2021 20:20 UTC